The study compared patients diagnosed with severe chronic low back pain due to spinal degeneration being treated with BMAC against patients treated with traditional pain management therapies. The treatment group received a one-time bone marrow aspirate concentrate injection into the affected area of the lumbar spine combined with traditional pain management therapies. The control group received only traditional pain management offerings (i.e. injections, anti-inflammatory drugs, prescribed medications, over-the-counter medications, physical therapy, ect.) Patients we studied over a period of twelve months, with outcomes being recorded at 1, 3, 6 and 12 months.
Patients in the treatment group showed significant improvement in function and pain reduction when compared to the control group at the twelve month assessment. For the full results of the study, follow the provided link below.